Mitochon Pharmaceuticals, Inc.

Calculating rank

USPTO Granted Patents = 7

EPO Patents = 3

Forward Citations = 24

Loading Chart...

5 inventors (with patents filed for the assignee):

John Gerard Geisler (7 out of 7 patents)

Robert Alonso (7 out of 18 patents)

Narsimha Reddy Penthala (2 out of 16 patents)

4. Zaineb Albayati (2 out of 2 patents)

5. Peter Anthony Crooks (2 out of 97 patents)

7 patents: Sort by Forward Citations

1. 11717497 - Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases (2023-08-08),

2. 11406642 - DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases (2022-08-09),

3. 10864173 - Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases (2020-12-15),

4. 10548900 - DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases (2020-02-04),

5. 10220006 - Induced expression of brain derived neurotrophic factor (BDNF) for treatment of Neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases (2019-03-05),

6. 9974755 - Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases (2018-05-22),

7. 9763896 - Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases (2017-09-19),

Company Overview

Mitochon Pharmaceuticals, Inc. is a biotechnology company focused on developing novel therapies for mitochondrial diseases. With a mission to improve the lives of patients suffering from mitochondrial dysfunction, Mitochon is at the forefront of research and innovation in this field. The company's pipeline includes promising drug candidates targeting various mitochondrial disorders, offering hope for those affected by these rare and debilitating conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#7 in Radnor, PA

#1,438 in Pennsylvania

#39,929 in US

Radnor, PA, United States of America

Mitochon Pharmaceuticals, Inc.

Forward Citations = 24

5 inventors:

John Gerard Geisler (7 out of 7 patents)

Robert Alonso (7 out of 18 patents)

Narsimha Reddy Penthala (2 out of 16 patents)

4. Zaineb Albayati (2 out of 2 patents)

5. Peter Anthony Crooks (2 out of 97 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mitochon Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/mitochon-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]